# SLR-108 PET Imaging in Subjects With Metastatic Solid Tumors

> **NCT07728942** · PHASE1 · RECRUITING · sponsor: **Solve Therapeutics** · enrollment: 70 (estimated)

## Conditions studied

- Metastatic Solid Tumors

## Interventions

- **DRUG:** SLR-108
- **DRUG:** SLX-1411

## Key facts

- **NCT ID:** NCT07728942
- **Lead sponsor:** Solve Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-04
- **Primary completion:** 2028-01
- **Final completion:** 2028-02
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07728942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07728942, "SLR-108 PET Imaging in Subjects With Metastatic Solid Tumors". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07728942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*